𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel point mutations in the dystrophin gene

✍ Scribed by Roberta Sitnik; Simone Campiotto; Mariz Vainzof; Rita C. Pavanello; Reinaldo I. Takata; Mayana Zatz; Maria Rita Passos-Bueno


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
131 KB
Volume
10
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


Communicated by Martin Bobrow

Duchenne (DMD) and Becker (BMD) type muscular dystrophies are allelic X-linked recessive disorders caused by mutations in the gene encoding dystrophin. About 65% of the cases are caused by deletions, while 5-10% are duplications. The remaining 30% of affected individuals may have smaller mutations (point mutations or small deletions/insertions) which cannot be identified by current diagnostic screening strategies. In order to look for pathogenic small mutations in the dystrophin gene, we have screened the 18 exons located in the hot spot region of this gene through two different single strand conformation polymorphism (SSCP) conditions. Five different pathogenic mutations were identified in 6 out of 192 DMD/BMD patients without detectable deletions: 2 nonsense, 1 bp insertion, 1 bp deletion and 1 intronic. Except for the intronic change, which alters a splice site, all the others cause a premature stop codon. In addition, 8 apparently neutral changes were identified. However, interestingly, one of them was not identified in 195 normal chromosomes, although it was previously described in a DMD patient from a different population. The possibility that this mutation may be pathogenic is discussed. Except for two neutral changes, all the others are apparently here described for the first time. Hum Mutat 10:217-222, 1997.


πŸ“œ SIMILAR VOLUMES


Three novel point mutations in the dystr
✍ Adriana Lasa; Pia Gallano; Montserrat Baiget πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 1 views

Duchenne muscular dystrophy (DMD) is an X-linked degenerative disorder of muscle, caused by gross rearrangements by the dystrophin gene in two-thirds of cases. The remaining one-third of patients may carry more subtle mutations that are difficult to detect because of the large size and complexity of

Dystrophin gene transcripts skipping the
✍ Stephen D. Wilton; Danielle E. Dye; Nigel G. Laing πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 226 KB πŸ‘ 1 views

The mdx mouse, an animal model used to study Duchenne muscular dystrophy, has a nonsense mutation in exon 23 of the dystrophin gene which should result in a truncated protein that cannot be correctly localized at the sarcolemma of the muscle fibers. Immunohistochemical staining with antidystrophin a

A novel βˆ’27A>G point mutation in the bet
✍ Silvia Fattore; Maurizio Travi; Paola Primignani; Anita Biasi; Federica Sbrocca; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 13 KB πŸ‘ 1 views
Identification of three novel mutations
✍ ChristΓ¨le Dubourg; Sylvie Odent; Patricia Fergelot; Jean-Yves Le Gall; VΓ©ronique πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked neuromuscular disorders associated with alterations in the dystrophin gene. Analysis of 45 DMD/BMD patients has identified 18 patients with no deletion in the dystrophin gene. Heteroduplex analysis (HD), single strand